Neuronetics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ

17 Mar 2026

STIM

10-K: Neuronetics Reports Strong Revenue Growth Amidst CEO Transition

Neuronetics, Inc. announced significant revenue growth for 2025, driven by the Greenbrook acquisition, alongside a new CEO appointment and ongoing efforts to improve profitability.

NASDAQ

27 Mar 2025

STIM

Neuronetics, INC

10-K: Neuronetics Reports 2024 Results, Highlights Greenbrook Acquisition Synergies

Neuronetics' 2024 10-K filing reveals a year of strategic shifts, including the acquisition of Greenbrook, aimed at expanding mental health treatment access.

NASDAQ

8 Mar 2024

STIM

Neuronetics, INC

10-K: Neuronetics 10-K Filing Reveals 9% Revenue Growth Amidst Net Loss

Neuronetics' annual 10-K filing shows a 9% increase in revenue to $71.3 million for 2023, alongside a net loss of $30.2 million.